SIG
GILD icon

Sargent Investment Group’s Gilead Sciences GILD Stock Holding History

Sargent Investment Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37M Sell
10,842
-202
-2% -$26.6K 0.16% 108
2026
Q1 		$1.54M Buy
11,044
+1,453
+15% +$203K 0.2% 93
2025
Q4 		$1.18M Sell
9,591
-1,737
-15% -$211K 0.15% 106
2025
Q3 		$1.26M Buy
11,328
+2,336
+26% +$266K 0.18% 87
2025
Q2 		$992K Buy
8,992
+2,576
+40% +$274K 0.13% 101
2025
Q1 		$719K Buy
6,416
+1,362
+27% +$141K 0.11% 117
2024
Q4 		$455K Buy
+5,054
New +$455K 0.07% 139
2020
Q4 		– Sell
-4,425
Closed -$280K – 192
2020
Q3 		$280K Sell
4,425
-1,109
-20% -$76.9K 0.1% 134
2020
Q2 		$421K Buy
+5,534
New +$424K 0.16% 104

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sargent Investment Group's GILD Position: Q2 2026 in Review

Sargent Investment Group reduced its Gilead Sciences (GILD) stake by 1.8% in Q2 2026, selling an estimated $26.6K and leaving 10,842 shares worth $1.37M. The position accounts for 0.16% of the portfolio, ranked #108.

Sargent Investment Group first reported a position in GILD in Q2 2020 and has held it in 9 quarters since. The position peaked at $1.54M in Q1 2026. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Sargent Investment Group held 10,842 shares of Gilead Sciences worth $1.37M as of Q2 2026.
  • Sargent Investment Group sold 202 Gilead Sciences shares in Q2 2026, an estimated $26.6K.
  • Gilead Sciences made up 0.16% of Sargent Investment Group's portfolio in Q2 2026, its #108 holding.
  • Sargent Investment Group first reported a position in Gilead Sciences in Q2 2020 and has held it in 9 quarters since.
  • Sargent Investment Group's Gilead Sciences position peaked at $1.54M in Q1 2026.
  • 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Sargent Investment Group's 13F filing for Q2 2026, filed 11 Aug 2026.